Myelomeningocele in an infant with intrauterine exposure to efavirenz

Journal of Perinatology

Volumn 25, Issue 8, 2005, Pages 555-556

  Saitoh, Akihiko ^a   Hull, Andrew D ^a   Franklin, Patricia ^a   Spector, Stephen A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; EFAVIRENZ; LAMIVUDINE; NEVIRAPINE; TENOFOVIR; VIRUS DNA; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CASE REPORT; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FETUS ECHOGRAPHY; HOSPITAL DISCHARGE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INFANT DISEASE; MALE; MENINGOMYELOCELE; MUSCLE WEAKNESS; NEWBORN; NONHUMAN; POLYMERASE CHAIN REACTION; PREGNANCY; PREGNANCY DIABETES MELLITUS; PRENATAL DRUG EXPOSURE; SURGICAL TECHNIQUE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTI-HIV AGENTS; ARNOLD-CHIARI MALFORMATION; FEMALE; HUMANS; INFANT, NEWBORN; MALE; MENINGOMYELOCELE; OXAZINES; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND;

EID: 23744490721     PISSN: 07438346     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jp.7211343     Document Type: Article

References (8)

1. Gulick RM, Ribaudo HJ, Shikuma CM, et al. Triple-nucleoside regimens versus efavirenz-containing regimens for the initial treatment of HIV-1 infection. N Engl J Med 2004;350:1850-61.
2. Staszewski S, Morales-Ramirez J, Tashima KT, et al. Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team. N Engl J Med 1999;341:1865-73.
3. Perinatal HIV Guidelines Working Group. Public Health Service Task Force. Recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States Available on at: http://www.aidsinfo.nih.gov/guidelinesupdated June 23, 2004. Accessed January 6, 2005.
4. Nightingale SL. From the food and drug administration. JAMA 1998;280:1472.
5. Fundaro C, Genovese O, Rendeli C, Tamburrini E, Salvaggio E. Myelomeningocele in a child with intrauterine exposure to efavirenz. AIDS 2002;16:299-300.
6. De Santis M, Carducci B, De Santis L, Cavaliere AF, Straface G. Periconceptional exposure to efavirenz and neural tube defects. Arch Intern Med 2002;162:355.
7. Antiretroviral Pregnancy Registry Steering Committee. Antiretroviral Pregnancy Registry International Interim Report for January 1989 through 31 January 2004. Wilmington, NC: Registry Coordinating Center; 2004. Available from URL: www.apregistry.com.
8. Botto LD, Moore CA, Khoury MJ, Erickson JD. Neural-tube defects. N Engl J Med 1999;341:1509-9.